Stay updated on Abaloparatide-SC in Men With Osteoporosis Clinical Trial
Sign up to get notified when there's something new on the Abaloparatide-SC in Men With Osteoporosis Clinical Trial page.

Latest updates to the Abaloparatide-SC in Men With Osteoporosis Clinical Trial page
- Check5 days agoChange DetectedClinicalTrials.gov’s release/version indicator on the page was updated from v3.5.2 to v3.5.3, reflecting a site software revision rather than a change to study information.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedAdded a PubMed-cited publication reference (The effects of abaloparatide on acetabular bone mineral density and proximal femur strength in men with osteoporosis) and a PubMed auto-fill note. Revision history updated to v3.5.0.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 in the page footer. This change only updates the site version label and does not alter study content or functionality.SummaryDifference0.0%

- Check78 days agoChange DetectedA new site revision tag, Revision: v3.4.2, was added, and the prior government funding status notice was removed. No trial data, eligibility criteria, or study results are affected.SummaryDifference0.3%

- Check85 days agoChange DetectedIntroduced a site-wide notice about government funding lapse and operation status, including links to cc.nih.gov and opm.gov. Updated site revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Abaloparatide-SC in Men With Osteoporosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abaloparatide-SC in Men With Osteoporosis Clinical Trial page.